Volume 11, Issue 1
Research Articlep. 1-9
Prophylactic administration of a clinically safe low dose of the COVID-19 drug candidate Rejuveinix (RJX) effectively prevents fatal cytokine storm and mitigates inflammatory organ injury in a mouse model of sepsis
Author(s): Fatih M. Uckun, Cemal Orhan, Ibrahim H. Ozercan, Nurhan Sahin, Joy Powell, Natalie Pizzimenti, Michael Volk, Kazim Sahin
Research Articlep. 10-18
Targeting TGF-beta pathway with COVID-19 Drug Candidate ARTIVeda/PulmoHeal Accelerates Recovery from Mild-Moderate COVID-19
Author(s): Vuong Trieu, Saran Saund, Prashant V. Rahate, Viljay B. Barge, K. Sunil Nalk, Hitesh Windlass, Fatih M. Uckun
Case Seriesp. 19-25
To assess AIDS awareness among the educated community of Lahore and Gujranwala, Pakistan
Author(s): Junaid Karamat Cheema, Abdul Salam, Aqil Khan, Muhammad Zeeshan Zafar
Case Seriesp. 26-30
Study the different incidences of Tramadol in different cities of Punjab, Pakistan
Author(s): Muhammad Javaid Iqbal, Mazhar Ali, Rizwan Ghafoor, Arif Mustafa khan, Muhammad Majid Raza
Imagep. 31-31
Use of Cladribine for multiple sclerosis treatment: An image article
Author(s): Jeniffer Stewert
